Agios Pharmaceuticals, Inc (AGIO) insider trading
Every open-market stock purchase and sale by Agios Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Sarah Gheuens (Executive) sold $1.3M in the last 90 days.
- Last company insider buy: Jacqualyn A Fouse (CEO), $1.2M, 6 years ago.
- Congress: Gilbert Cisneros bought $1K to $15K, 2 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $4.9M (26 sales). Last close $30.55 on Oct 30, 2026.
Recent AGIO insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 26, 2026 | Sarah Gheuens (C-suite exec) | Sold | $296K |
| Oct 26, 2026 | Sarah Gheuens (C-suite exec) | Bought (not open market) | $197K |
| Oct 26, 2026 | Sarah Gheuens (C-suite exec) | Bought (not open market) | — |
| Oct 22, 2026 | Sarah Gheuens (C-suite exec) | Sold | $18.8K |
| Oct 22, 2026 | Sarah Gheuens (C-suite exec) | Bought (not open market) | $12.5K |
| Oct 22, 2026 | Sarah Gheuens (C-suite exec) | Bought (not open market) | — |
| Oct 21, 2026 | Sarah Gheuens (C-suite exec) | Sold | $55.9K |
| Oct 21, 2026 | Sarah Gheuens (C-suite exec) | Bought (not open market) | $37.2K |
| Oct 21, 2026 | Sarah Gheuens (C-suite exec) | Bought (not open market) | — |
| Aug 20, 2026 | Gilbert Cisneros (Representative) | Bought | $1K–15K |
| Aug 4, 2026 | Sarah Gheuens (C-suite exec) | Sold | $914K |
| Jul 8, 2026 | Jay T. Backstrom (Director) | Bought (not open market) | — |
| Jul 8, 2026 | Jay T. Backstrom (Director) | Bought (not open market) | — |
| Jul 1, 2026 | Sarah Gheuens (C-suite exec) | Sold | $151K |
| Jul 1, 2026 | Sarah Gheuens (C-suite exec) | Bought (not open market) | — |
| Jul 1, 2026 | Sarah Gheuens (C-suite exec) | Bought (not open market) | — |
| Jun 18, 2026 | Jacqualyn A Fouse (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Jay T. Backstrom (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Krishnan Viswanadhan (Officer) | Bought (not open market) | — |
| Jun 18, 2026 | Tsveta Milanova (C-suite exec) | Bought (not open market) | — |
| Jun 18, 2026 | Jeffrey D Capello (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Brian Goff (CEO) | Bought (not open market) | — |
| Jun 18, 2026 | Rahul D. Ballal (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Cynthia Smith (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Kaye I Foster-Cheek (Director) | Bought (not open market) | — |
Who's trading AGIO
- Sarah Gheuens, C-suite exec: sold $1.8M (10 sales), last Oct 26, 2026
- Gilbert Cisneros, Representative: bought $24K (3 buys), last Aug 20, 2026
- Jay T. Backstrom, Director: other filings, last Jul 8, 2026
- Jeffrey D Capello, Director: other filings, last Jun 18, 2026
- Jacqualyn A Fouse, Director: other filings, last Jun 18, 2026
- Kaye I Foster-Cheek, Director: other filings, last Jun 18, 2026
- Brian Goff, CEO: sold $1.7M (7 sales), last Jun 18, 2026
- Maykin Ho, Director: other filings, last Jun 18, 2026
- Cecilia Jones, CFO: sold $334K (6 sales), last Jun 18, 2026
- Rahul D. Ballal, Director: other filings, last Jun 18, 2026
- James William Burns, C-suite exec: sold $310K (5 sales), last Jun 18, 2026
- Adams Catherine Owen, Director: other filings, last Jun 18, 2026
- David Scadden, Director: sold $8.8K (1 sale), last Jun 18, 2026
- Cynthia Smith, Director: other filings, last Jun 18, 2026
- Krishnan Viswanadhan, Officer: sold $185K (2 sales), last Jun 18, 2026
Get free alerts when an insider at Agios Pharmaceuticals, Inc files a new trade →